Press Releases CanSino Biologics Inc.

Equities

6185

CNE100003F01

Market Closed - Hong Kong S.E. Other stock markets 04:08:20 2024-04-26 am EDT			5-day change	1st Jan Change
18.82 ^HKD	+2.51%		+14.06%	-20.08%

Apr. 22	Cansino Bio Gets Nod for China Clinical Trials of Haemophilus Influenzae Vaccine	MT
Apr. 22	Cansino Biologics Pneumococcal Vaccine's Phase I Trial Offers Positive Results	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

CanSinoBIO CSO Shares the Latest Results of the Company's Globally Innovative Pneumococcal Vaccine	Apr. 26	AQ
The Commercialization of Asia's First Meningococcal Conjugate Vaccine From CanSinoBIO Represents a Significant Breakthrough	Mar. 27	AQ
CanSino Biologics : CanSinoBIO Initiates Phase Ⅲ Clinical Trial of Group ACYW135 Meningococcal Conjugate Vaccine Menhycia® in Indonesia	Mar. 24	PU
CanSino Biologics : CanSinoBIO and SPIMACO Forge Strategic Partnership to Advance Accessibility of Cutting-Edge Vaccines	Dec. 18	PU
CanSino Biologics : CanSinoBIO Kicks-off the Polio VLP Vaccine Cooperation	Dec. 04	PU
CanSino Biologics : CanSinoBIO's Convidecia Air® Receives Approval in Indonesia	23-03-01	PU
CanSino Biologics : Latest Study Shows Encouraging Results of CanSinoBIO’s mRNA COVID-19 Vaccine as Heterologous Booster	23-02-19	PU
CanSino Biologics : Solution Group Berhad to Start Local Fill and Finish of CanSinoBIO’s COVID-19 Vaccine in Malaysia	23-02-12	PU
CanSino Biologics : CanSinoBIO Announces Encouraging Clinical Progress of its COVID-19 mRNA Vaccine	23-01-06	PU
First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco	22-12-30	AQ
CanSino Biologics : First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco	22-12-28	PU
CanSino Biologics : CanSinoBIO Leads Sino-Indonesian Collaboration on Mucosal Vaccine Development	22-11-17	PU
CanSino Biologics : CanSinoBIO’s Convidecia Air™ Approved for Emergency Use in Morocco	22-11-10	PU
CanSino Biologics : and AstraZeneca Sign Strategic Collaboration Agreement to Deepen Research on Rare Diseases	22-11-10	PU
CanSino Biologics : Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai	22-10-25	PU
CanSino Biologics : CanSinoBIO to Present Latest Data on Convidecia Air™ at the World Vaccine Congress Europe 2022	22-10-06	PU
CanSino Biologics : CanSinoBIO's Convidecia Air™ Receives Approval in China	22-09-04	PU
CanSino Biologics : Convidecia Air™ Receives Clinical Trial Approval in Malaysia	22-08-18	PU
CanSinoBIO's COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing	22-05-19	AQ
WHO clears China's CanSino COVID vaccine for emergency use	22-05-19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

INTERVIEW - Xuefeng Yu, CEO of CanSino Biologics: Behind the scenes of the agreement with AstraZeneca

August 31, 2023 at 06:08 am EDT